Company profile

Ticker
HWKN
Exchange
CEO
Patrick H. Hawkins
Employees
Incorporated in
Location
Fiscal year end
Former names
Hawkins Chemical Inc
SEC CIK
IRS number
410771293

HWKN stock data

(
)
FINRA relative short interest over last month (20 trading days) ?

Calendar

6 Feb 20
4 Apr 20
29 Mar 21

News

Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 120.41M 140.04M 147.34M 133.05M
Net income 4.55M 9.25M 9.81M 3.77M
Diluted EPS 0.43 0.87 0.92 0.35
Net profit margin 3.78% 6.61% 6.66% 2.83%
Operating income 6.78M 13.18M 13.96M 5.79M
Net change in cash 3.21M -1.55M -3.59M 1.9M
Cash on hand 7.27M 4.06M 5.61M 9.2M
Cost of revenue 98.93M 112.05M 118.54M 112.38M

Financial data from Hawkins earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
1 Apr 20 Oldenkamp Jeffrey P. Common Stock Payment of exercise Dispose F 32.69 1,657 54.17K 16,970.706
31 Jul 19 Duane M Jergenson Common Stock Grant Aquire A 0 1,144 0 35,019
31 Jul 19 John S Mckeon Common Stock Grant Aquire A 0 1,144 0 47,087.225
31 Jul 19 Mary J. Schumacher Common Stock Grant Aquire A 0 1,144 0 9,152
31 Jul 19 James A Faulconbridge Common Stock Grant Aquire A 0 1,144 0 14,998
13F holders
Current Prev Q Change
Total holders 121 126 -4.0%
Opened positions 10 10
Closed positions 15 9 +66.7%
Increased positions 37 44 -15.9%
Reduced positions 44 45 -2.2%
13F shares
Current Prev Q Change
Total value 451.28M 336.38M +34.2%
Total shares 6.45M 6.35M +1.5%
Total puts 6.6K 9 +73233.3%
Total calls 0 0
Total put/call ratio Infinity Infinity NaN%
Largest owners
Shares Value Change
BLK BlackRock 1.53M $70.26M +5.5%
Vanguard 770.46K $35.29M +1.6%
Dimensional Fund Advisors 610.53K $27.97M +0.2%
N Price T Rowe Associates 605.68K $27.75M -0.5%
STT State Street 298.73K $13.69M +6.4%
WFC Wells Fargo & Co. 158.29K $7.25M +2.2%
BK Bank Of New York Mellon 146.28K $6.7M -7.3%
NTRS Northern Trust 142.65K $6.54M +0.8%
Geode Capital Management 133.37K $6.11M +1.7%
GW&K Investment Management 101.52K $4.65M -6.1%
Largest transactions
Shares Bought/sold Change
BLK BlackRock 1.53M +79.38K +5.5%
JPM JPMorgan Chase & Co. 63.22K +36.99K +141.1%
BMO Bank Of Montreal 24.86K +20.71K +498.3%
MS Morgan Stanley 52.77K +19.74K +59.8%
Mackay Shields 19.54K -19.5K -50.0%
STT State Street 298.73K +17.89K +6.4%
IVZ Invesco 42.21K -16.21K -27.8%
Advisor 27.53K +14.62K +113.3%
Panagora Asset Management 64.19K +12.34K +23.8%
Vanguard 770.46K +12.11K +1.6%

Financial report summary

?
Risks
  • Environmental problems at any of our facilities could result in significant unexpected costs.
  • Our food, pharmaceutical and nutritional products are subject to government regulation, both in the United States and abroad, which could increase our costs significantly and limit or prevent the sale of such products.
  • Our businesses expose us to potential product liability claims and recalls, which could adversely affect our financial condition and performance.
  • Demand for our food and nutritional products is highly dependent upon consumers’ perception of the safety and quality of our products, our customers’ products as well as similar products distributed by other companies, and adverse publicity and negative public perception regarding particular ingredients or products or the nutraceuticals industry in general could limit our ability to increase revenue and grow that portion of our business.
  • The insurance that we maintain may not fully cover all potential exposures.
  • Failure to comply with the covenants under our credit facility may have a material adverse effect.
  • Impairment to the carrying value of our goodwill or other intangible assets could adversely affect our financial condition and consolidated results of operations.
Management Discussion
  • Sales decreased $7.8 million, or 6.0%, to $120.4 million for the three months ended December 29, 2019, as compared to $128.2 million for the same period of the prior year.
  • Industrial Segment. Industrial segment sales decreased $6.0 million, or 8.7%, to $63.0 million for the three months ended December 29, 2019, as compared to $69.0 million for the same period of the prior year. Sales of bulk commodity products in the Industrial segment were approximately 18% of sales dollars for the current quarter and 23% for the same period in the prior year. Sales dollars decreased from the prior year due to lower overall sales volumes, particularly of lower-priced bulk commodities driven by a weak ethanol industry, as well as lower pricing due to lower costs of one of our major commodities.
  • Water Treatment Segment. Water Treatment segment sales increased $2.2 million, or 6.6%, to $34.9 million for the three months ended December 29, 2019, as compared to $32.7 million for the same period of the prior year. Sales of bulk commodity products in the Water Treatment segment were approximately 12% of sales dollars for the current quarter and 16% of sales dollars for the same period in the prior year. The increase in sales dollars was driven by increased volumes sold of certain manufactured, blended and re-packaged products that carry higher per-unit selling prices, offset somewhat by lower pricing due to lower costs of one of our major commodities.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Good
New words: branch, chapter, check, deduction, electronically, emerging, EmployerIdentification, ethanol, experienced, filer, Interactive, issuer, mark, past, preceding, provision, registered, registrant, Regulation, Rule, Shareholder, shell, shorter, submit, submitted, unfavorable, WASHINGTON, weak
Removed: acquisition, arose, FASB, indemnification, offsetting, receivable, reclassified, relevant, retainer, spending, Stauber, taxing, uncertain, unrecognized